| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.
|
Br J Addict
|
1991
|
63.91
|
|
2
|
Biochemical verification of tobacco use and cessation.
|
Nicotine Tob Res
|
2002
|
14.54
|
|
3
|
Measures of abstinence in clinical trials: issues and recommendations.
|
Nicotine Tob Res
|
2003
|
11.72
|
|
4
|
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
|
N Engl J Med
|
1999
|
10.62
|
|
5
|
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
|
JAMA
|
2006
|
10.54
|
|
6
|
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
|
JAMA
|
2006
|
10.31
|
|
7
|
Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.
|
J Med Chem
|
2005
|
6.13
|
|
8
|
Bupropion: a review of its mechanism of antidepressant activity.
|
J Clin Psychiatry
|
1995
|
3.30
|
|
9
|
Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
|
Arch Intern Med
|
2006
|
3.30
|
|
10
|
Extended nortriptyline and psychological treatment for cigarette smoking.
|
Am J Psychiatry
|
2004
|
1.87
|
|
11
|
Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial.
|
Prev Med
|
1995
|
1.85
|
|
12
|
A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.
|
Arch Intern Med
|
2006
|
1.78
|
|
13
|
A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
|
J Clin Psychopharmacol
|
2007
|
1.66
|
|
14
|
The effect of bupropion on nicotine craving and withdrawal.
|
Psychopharmacology (Berl)
|
2000
|
1.52
|
|
15
|
Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers.
|
J Consult Clin Psychol
|
2004
|
1.41
|
|
16
|
Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy.
|
Exp Clin Psychopharmacol
|
1998
|
1.38
|
|
17
|
Combination nicotine replacement therapy for smoking cessation: rationale, efficacy and tolerability.
|
CNS Drugs
|
2001
|
1.37
|
|
18
|
Efficacy of bupropion alone and in combination with nicotine gum.
|
Nicotine Tob Res
|
2007
|
1.33
|
|
19
|
Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial.
|
Arch Intern Med
|
2000
|
1.25
|
|
20
|
Behavioral and biochemical investigations of bupropion metabolites.
|
Eur J Pharmacol
|
2003
|
1.25
|
|
21
|
Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.
|
Mayo Clin Proc
|
2007
|
1.19
|
|
22
|
How does bupropion work as a smoking cessation aid?
|
Addict Biol
|
2005
|
1.09
|
|
23
|
Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized setting.
|
Nicotine Tob Res
|
2003
|
1.07
|
|
24
|
Bupropion for the treatment of nicotine withdrawal and craving.
|
Expert Rev Neurother
|
2006
|
1.05
|
|
25
|
Naltrexone and nicotine patch smoking cessation: a preliminary study.
|
Nicotine Tob Res
|
2003
|
1.03
|
|
26
|
Nicotine patch and paroxetine for smoking cessation.
|
J Consult Clin Psychol
|
2000
|
1.01
|
|
27
|
Pharmacokinetic optimisation of sustained-release bupropion for smoking cessation.
|
Drugs
|
2002
|
1.00
|
|
28
|
A randomized controlled trial of oral selegiline plus nicotine skin patch compared with placebo plus nicotine skin patch for smoking cessation.
|
Addiction
|
2003
|
0.99
|
|
29
|
Combination treatment for nicotine dependence: state of the science.
|
Subst Use Misuse
|
2005
|
0.91
|
|
30
|
Effect of bupropion on physiological measures of stress in smokers during nicotine withdrawal.
|
Pharmacol Biochem Behav
|
2006
|
0.86
|
|
31
|
Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.
|
Exp Clin Psychopharmacol
|
2005
|
0.82
|
|
32
|
Concurrent agonist-antagonist administration for the analysis and treatment of drug dependence.
|
Pharmacol Biochem Behav
|
1992
|
0.77
|
|
33
|
Nicotine chewing gum and nicotine patch.
|
Wien Med Wochenschr
|
1995
|
0.75
|
|
34
|
Naltrexone-bupropion combination therapy for protracted abstinence dysphoria.
|
Am J Addict
|
2003
|
0.75
|